Vanderbilt University School of Medicine
17
3
5
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 17 trials
100.0%
+13.5% vs industry average
18%
3 trials in Phase 3/4
22%
2 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Antibiotic Prophylaxis in Rhinoplasty
Role: collaborator
BXCL501 After Stress to Increase Recovery Success
Role: collaborator
Sickle Cell Clinical Research and Intervention Program
Role: collaborator
Targeting Hypervigilance and Autonomic Arousal: the Psycho-physiologic Model of Gastroesophageal Reflux Disease (GERD)
Role: collaborator
Study of Radiation Exposure and Bilateral Breast Cancer
Role: collaborator
Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery
Role: collaborator
Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
Role: collaborator
The Diagnostic Experience of Male Rett Syndrome
Role: collaborator
Physical Activity to Reduce Diabetes Risk in Serious Mental Illness
Role: collaborator
A Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients
Role: collaborator
A Pilot Study of Rehabilitation Among Intensive Care Unit (ICU) Survivors: the RETURN Trial
Role: collaborator
Peripheral Chemoreflex/Arterial Baroreflex Interaction in Patients With Electrical Carotid Sinus Stimulation
Role: collaborator
Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides
Role: collaborator
Biomarkers of Molecular Risk in Smokers
Role: collaborator
Center for Reducing Asthma Disparities - Meharry/Vanderbilt Centers
Role: collaborator
HIV Resistance and Treatment Strategies
Role: collaborator
Very Early Surfactant and NCPAP for Premature Infants With RDS
Role: collaborator
All 17 trials loaded